温馨提示:本站仅提供公开网络链接索引服务,不存储、不篡改任何第三方内容,所有内容版权归原作者所有
AI智能索引来源:http://www.vida.com/case-study/reducing-glp-1-spend-while-driving-meaningful-weight-loss
点击访问原文链接

CapRx Case Study - Vida

CapRx Case Study - Vida Skip to content Enterprise Back Vida for Enterprise

Explore what Vida Health can do for your organization.

Contact us Working with us Overview Employers Partners Health Plans How Vida delivers Vida’s approach Programs Metabolic Care Our providers The Vida app Outcomes Research Individuals Back Vida for Individuals

Take charge of your health today.

Support Log in Get started Create your account Your privacy The Vida experience What’s Vida like? How we help What we treat Multicultural support Resources About Back About Vida

Let’s fix healthcare and heal people.

Contact us Working at Vida Our team News Login Contact Sales Toggle Mobile Navigation Case Study CapRx Case Study

See the outcomes of a coordinated solution that pairs Vida’s personalized care with Judi® -driven medication management promoting behavior change and appropriate use of GLP-1s.

April 28, 2026 Reducing GLP-1 spend while driving meaningful weight loss $403PMPMestimated pharmacy savings Driven by optimized GLP-1 utilization

Members were guided to the most appropriate care path, whether behavior change alone, GLP-1s, or lower-cost anti-obesity medications (AOMs).

4% 24% 18% 54% n=299 GLP-1 Lower cost AOM Behavior change GLP-1 + lower cost AOM Most members did not use GLP-1s
Managing rising GLP-1 costs with smarter, coordinated care

With GLP-1 spend reaching over $70 billion without consistent clinical oversight, employers face growing pressure to manage cost and outcomes. Vida and Capital Rx deliver a coordinated solution that pairs personalized care with Judi®-driven medication management to promote behavior change and appropriate use of GLP-1s.

Members achieved sustained weight loss with and without GLP-1s > 11.6%

weight loss at
12 months (GLP-1s)

> 6.0%

weight loss at 12 months (Behavior change and/or low-cost medication)*

*clinically significant weight loss is > 5%

High engagement without medication dependence Members participated in 39 lifestyle activities/month on average Over ~10 months of participation

Mooney K, Munro C, Voelker L, Venkatesan A. The impact of Capital Rx’s Rx Activate program in partnership with Vida on GLP-1 and anti-obesity medication utilization, weight loss, and inferred cost avoidance. AMCP Annual Meeting; 2026.

Rx Activate member spotlight: Adam’s results

Achieved through personalized coaching, nutrition support, and consistent engagement.

Download case study Resources More resources Article What a Whole Health Solution Actually Means — and Why Metabolic Care Is Central to It

While many solutions have attempted to make “whole health” the center of their care model, conflicting definitions have muddled the process. What does whole health really mean, and where does metabolic care fit in?

Blog Post GLP-1s were meant for chronic disease. How did they become a cosmetic trend?

If solving the obesity crisis was just about dropping pounds, with the help of GLP-1s, we’d have already accomplished that task. But, weight loss is more than a checked box or renewed prescription. It’s a lifestyle change.

Blog Post Erica Terry’s Transformation Through Sustainable Behavior Change

Conversations about weight loss often center on diets, medications, or the number on the scale. But for our very own Erica Terry, Director of Sales, Payer/PBM at Vida Health, the most important lesson was much simpler and far more powerful…

support@vida.com

Your Privacy Choices

Individuals

How we help Get started Member support

Enterprise

Who we work with Our approach Privacy policy Accessibility statement Non-discrimination notice Terms of use Personnel privacy notice Instagram Facebook LinkedIn App store download Google play download

© 2026 Vida Health, Inc. All rights reserved.

CapRx Case Study - Vida,AI智能索引,全网链接索引,智能导航,网页索引

    See the outcomes of a coordinated solution that pairs Vida